Virtual monochromatic image at lower energy level for assessing pancreatic ductal adenocarcinoma in fast kV-switching dual-energy CT.
Sign Up to like & getrecommendations! Published in 2019 at "Clinical radiology"
DOI: 10.1016/j.crad.2019.11.012
Abstract: AIM To evaluate the value of virtual monochromatic images (VMIs) at lower energy levels in fast-voltage-switching dual-energy computed tomography (DECT) for assessing pancreatic ductal adenocarcinoma (PDAC). MATERIALS AND METHODS The institutional review board approved this… read more here.
Keywords: kev; lower energy; switching dual; energy ... See more keywords
Switching from dual antiplatelet therapy with aspirin plus a P2Y12 inhibitor to dual pathway inhibition with aspirin plus vascular-dose rivaroxaban.
Sign Up to like & getrecommendations! Published in 2023 at "Thrombosis and haemostasis"
DOI: 10.1055/a-2098-6639
Abstract: BACKGROUND To date, there is no data on switching to dual pathway inhibition (DPI) patients who have completed a guideline-recommended dual antiplatelet therapy (DAPT) regimen. OBJECTIVES To assess the feasibility of switching from DAPT to… read more here.
Keywords: switching dual; inhibition; dual pathway; aspirin plus ... See more keywords
EVALUATION OF PATIENT EXPOSURE IN FAST kVp SWITCHING DUAL ENERGY COMPUTED TOMOGRAPHY: PHANTOM STUDY
Sign Up to like & getrecommendations! Published in 2018 at "Radiation Protection Dosimetry"
DOI: 10.1093/rpd/ncy022
Abstract: The aim of this study was to evaluate the suitability of size specific dose estimates (SSDE) to estimate patient dose in Fast kVp switching dual energy CT. An anthropomorphic phantom (RAN-110) was repeatedly scanned (chest,… read more here.
Keywords: dual energy; kvp switching; switching dual; fast kvp ... See more keywords
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: a multicenter retrospective cohort study from 2007 to 2015
Sign Up to like & getrecommendations! Published in 2018 at "BMC Infectious Diseases"
DOI: 10.1186/s12879-018-3198-2
Abstract: BackgroundTriple-drug regimens are the gold standard for HIV therapy. Nucleos(t)ide reverse transcriptase inhibitors (NRTIs) reducing regimens are used to decrease drugs toxicity, exposure and costs. Aim of our study was to evaluate trends of biochemical… read more here.
Keywords: biochemical inflammatory; switching dual; cd8; 2007 2015 ... See more keywords
Inflammatory Markers after Switching to a Dual Drug Regimen in HIV-Infected Subjects: A Two-Year Follow-Up
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v14050927
Abstract: Objective: Immunadapt is a study evaluating the impact of combination antiretroviral treatment (cART) simplification on immune activation. We previously showed that switching to dual therapies could be associated six months later with macrophage activation. Followup… read more here.
Keywords: switching dual; inflammatory markers; markers switching; dual drug ... See more keywords
Discrimination of papillary renal cell carcinoma from benign proteinaceous cyst based on iodine and water content on rapid kV-switching dual-energy CT
Sign Up to like & getrecommendations! Published in 2020 at "Diagnostic and Interventional Radiology"
DOI: 10.5152/dir.2020.19483
Abstract: PURPOSE We aimed to evaluate whether rapid kV-switching dual energy CT (rsDECT) can discriminate between papillary renal cell carcinoma (RCC) and benign proteinaceous cysts (BPCs) based on iodine and water content. METHODS Twenty-four patients with… read more here.
Keywords: switching dual; water; content; iodine water ... See more keywords